Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history now shows an added revision entry for v3.7.0 and the removal of v3.6.6, indicating the page’s version history was updated to reflect the latest documentation of changes.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe version history now includes a new entry Revision: v3.6.6 and the previous Revision: v3.6.5 entry is removed.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history now includes a new revision entry labeled v3.6.5 and removes the previous entry v3.6.4 from the version list. This updates the visible historical versions for the study record.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history now shows a new entry for Revision: v3.6.4 and removes Revision: v3.6.3. This updates the record history to reflect the latest software release.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry, v3.6.3, was added to the record history and the previous revision, v3.6.2, was removed, reflecting an updated version of the study record.SummaryDifference0.1%

- Check96 days agoChange DetectedA new revision entry labeled v3.6.2 has been added to the study's history. The previous v3.6.0 entry has been removed, reflecting an update to the record's version history.SummaryDifference0.1%

Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.